3-D MRI shows early signs of stroke risk in diabetic patients
People with diabetes may be harbouring advanced vascular disease that could increase their risk of stroke, according to new research led by Dr. Tishan Maraj, imaging analyst at Sunnybrook.
The findings, presented recently at the annual meeting of the Radiological Society of North America, suggest that arterial imaging with 3-D MRI could be useful in helping to determine stroke risk among diabetics.
“A recent analysis of multiple studies has shown that people with carotid artery narrowing and intraplaque hemorrhage have a five- to six-times higher risk of stroke in the near future compared to people without,” said Dr. Maraj, a M. Sc. candidate at the University of Toronto.
Dr. Maraj and colleagues focused their study on people with diabetes, a group already facing a significantly increased risk of strokes with worse outcomes than the non-diabetic population.
The researchers used 3-D MRI to study the carotid arteries for evidence of intraplaque hemorrhage (IPH), an indicator of advanced atherosclerotic disease.
Thirty-seven of 159 patients imaged had IPH in at least one carotid artery, five of which had IPH in both carotid arteries. IPH was found in the absence of carotid artery stenosis and was associated with an increased carotid artery wall volume.
The carotid arteries are vessels on each side of the neck that supply oxygenated blood to the head. Narrowing of the carotid arteries is associated with risk of stroke, but less is known about stroke risk in people with little or no narrowing of these arteries.
While 2-D MRI has been used for more than a decade to identify and characterize carotid artery plaques, the 3-D method brings an extra level of imaging power, Dr. Maraj noted. “The advantage of 3-D MRI is you can image the entire carotid artery and pinpoint the area of interest over a shorter period of time compared with multiple 2-D sequences,” he said.
Dr. Maraj emphasized that the study did not look at outcomes for the patients and did not draw any conclusions on whether people with IPH will develop carotid artery blockages more quickly than those with no IPH present. However, it is already known that blood is a destabilizing factor of plaque that promotes rupture, setting off a chain of events that can lead to a stroke.
Although there is no treatment for IPH at this time, Dr. Maraj said identification of it may help with risk stratification and could even have applications in the non-diabetic population.
“Even though you can’t treat IPH, you can monitor patients a lot more closely,” he said.
Visit the Radiological Society of North America for more details and the study abstract
